Terms: = Leukemia AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3 AND Treatment
105 results:
1. High throughput screening aids clinical decision-making in refractory acute myeloid leukaemia.
Jessop SJ; Fuentos-Bolanos N; Mayoh C; Dolman MEM; Tax G; Wong-Erasmus M; Ajuyah P; Tyrell V; Marshall GM; Ziegler DS; Lau LMS
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2061. PubMed ID: 38662349
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM).
Mill CP; Fiskus WC; DiNardo CD; Reville P; Davis JA; Birdwell CE; Das K; Hou H; Takahashi K; Flores L; Ruan X; Su X; Loghavi S; Khoury JD; Bhalla KN
Blood Cancer J; 2024 Feb; 14(1):25. PubMed ID: 38316746
[TBL] [Abstract] [Full Text] [Related]
3. Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and evi1 overexpression.
Birdwell CE; Fiskus W; Kadia TM; Mill CP; Sasaki K; Daver N; DiNardo CD; Pemmaraju N; Borthakur G; Davis JA; Das K; Sharma S; Horrigan S; Ruan X; Su X; Khoury JD; Kantarjian H; Bhalla KN
Leukemia; 2024 Mar; 38(3):545-556. PubMed ID: 38086946
[TBL] [Abstract] [Full Text] [Related]
4. A primary pediatric acute myelomonocytic leukemia with t(3;21)(q26;q22): A case report.
Duan JX; Liu F; Chang L; Che GL; Yang QX; Teng J; Jian H; Liu XJ; Lai SY
Medicine (Baltimore); 2023 Oct; 102(43):e35721. PubMed ID: 37904382
[TBL] [Abstract] [Full Text] [Related]
5. Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies.
Senapati J; Fiskus WC; Daver N; Wilson NR; Ravandi F; Garcia-Manero G; Kadia T; DiNardo CD; Jabbour E; Burger J; Short NJ; Alvarado Y; Jain N; Masarova L; Issa GC; Qiao W; Khoury JD; Pierce S; Miller D; Sasaki K; Konopleva M; Bhalla KN; Borthakur G; Pemmaraju N
Clin Cancer Res; 2023 Nov; 29(21):4352-4360. PubMed ID: 37585491
[TBL] [Abstract] [Full Text] [Related]
6. Identifying prognostic gene panels in acute myeloid leukemia.
Sanchez-Garcia J; Serrano J; Prados de La Torre E; Serrano-López J; Aparicio-Perez C; Barragán E; Montesinos P
Expert Rev Hematol; 2023 Apr; 16(4):277-287. PubMed ID: 36951195
[TBL] [Abstract] [Full Text] [Related]
7. Case report: A rare case of coexisting Waldenstrom Macroglobulinemia and B-cell acute lymphoblastic leukemia with KMT2D and mecom mutations.
Wang L; Tang J; Feng J; Huang Y; Cheng Y; Xu H; Miao Y
Front Immunol; 2022; 13():1001482. PubMed ID: 36325357
[TBL] [Abstract] [Full Text] [Related]
8. evi1 upregulates PTGS1 (COX1) and decreases the action of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia cells.
Vinothkumar K; Chanda S; Singh VK; Biswas S; Mohapatra S; Biswas G; Chakraborty S
Int J Hematol; 2023 Jan; 117(1):110-120. PubMed ID: 36282419
[TBL] [Abstract] [Full Text] [Related]
9. The CGRP Receptor Antagonist MK0974 Induces evi1
Suekane A; Ichikawa T; Saito Y; Nakahata S; Morishita K
Anticancer Res; 2022 Oct; 42(10):4743-4752. PubMed ID: 36191988
[TBL] [Abstract] [Full Text] [Related]
10. evi1 drives leukemogenesis through aberrant ERG activation.
Schmoellerl J; Barbosa IAM; Minnich M; Andersch F; Smeenk L; Havermans M; Eder T; Neumann T; Jude J; Fellner M; Ebert A; Steininger M; Delwel R; Grebien F; Zuber J
Blood; 2023 Feb; 141(5):453-466. PubMed ID: 36095844
[TBL] [Abstract] [Full Text] [Related]
11. [Clinical features of children with
Wu F; Tian J; She Z; Liu Y; Wan W; Wen C
Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):780-784. PubMed ID: 35673925
[TBL] [Abstract] [Full Text] [Related]
12. Resurgence of myeloproliferative neoplasm in patients in remission from blast transformation after treatment with hypomethylating agents.
Chauvet P; Nibourel O; Berthon C; Goursaud L; Carpentier B; Lionne-Huyghe P; Wemeau M; Quesnel B
Leuk Res; 2022 Jul; 118():106871. PubMed ID: 35633618
[TBL] [Abstract] [Full Text] [Related]
13. Clinical and Genomic Profiles of Korean Patients with
Lee J; Kim SM; Kim S; Yun J; Jeong D; Lee YE; Roh EY; Lee DS
Ann Lab Med; 2022 Sep; 42(5):590-596. PubMed ID: 35470277
[TBL] [Abstract] [Full Text] [Related]
14.
Elsherif M; Hammad M; Hafez H; Yassin D; Ashraf M; Yasser N; Lehmann L; Elhaddad A
Acta Oncol; 2022 Apr; 61(4):516-522. PubMed ID: 35038958
[TBL] [Abstract] [Full Text] [Related]
15. A novel algorithmic approach to generate consensus treatment guidelines in adult acute myeloid leukaemia.
Coats T; Bean D; Basset A; Sirkis T; Brammeld J; Johnson S; Thomas I; Gilkes A; Raj K; Dennis M; Knapper S; Mehta P; Khwaja A; Hunter H; Tauro S; Bowen D; Jones G; Dobson R; Russell N; Dillon R
Br J Haematol; 2022 Mar; 196(6):1337-1343. PubMed ID: 34957541
[TBL] [Abstract] [Full Text] [Related]
16. A novel intensive conditioning regimen for allogeneic hematopoietic stem cell transplantation in the treatment of relapsed/refractory acute myeloid leukemia.
Sun Y; Zhang J; Long B; Zhang X; Wen R; He Y; Li X
Neoplasma; 2021 Nov; 68(6):1351-1358. PubMed ID: 34641697
[TBL] [Abstract] [Full Text] [Related]
17. [Analysis of Clinical Characteristics and Prognosis in Children with Acute Megakaryoblastic leukemia without Down Syndrome].
Lin SF; Guo SY; Liu S; Wang J; Huang K; Li Y; Fang JP; Zhou DH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):374-380. PubMed ID: 33812402
[TBL] [Abstract] [Full Text] [Related]
18. BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone.
Behrens YL; Schienke A; Davenport C; Lentes J; Tauscher M; Steinemann D; Rasche M; Knirsch S; Joachim S; Reinhardt D; Schlegelberger B; Göhring G
Cancer Genet; 2021 Jun; 254-255():70-74. PubMed ID: 33647814
[TBL] [Abstract] [Full Text] [Related]
19. Targeted RNA-Sequencing Enables Detection of Relevant Translocations and Single Nucleotide Variants and Provides a Method for Classification of Hematological Malignancies-RANKING.
de Lange K; de Boer EN; Bosga A; Alimohamed MZ; Johansson LF; Mulder AB; Vellenga E; van Diemen CC; Deelen P; van den Berg E; Sikkema-Raddatz B
Clin Chem; 2020 Dec; 66(12):1521-1530. PubMed ID: 33257979
[TBL] [Abstract] [Full Text] [Related]
20. evi1 oncoprotein expression and CtBP1-association oscillate through the cell cycle.
Paredes R; Schneider M; Pearson S; Teng HY; Kelly JR; Pierce A; Somervaille TCP; Whetton AD; Meyer S
Mol Biol Rep; 2020 Oct; 47(10):8293-8300. PubMed ID: 32979164
[TBL] [Abstract] [Full Text] [Related]
[Next]
